StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Biogen Inc.
NasdaqGS:BIIB
Sector
Industries
Location
Market Cap
USD 19.27 B
Share Price
USD 131.52
Avg Daily Volume
1,561,840
Change (1 day)
-0.81%
Change (1 year)
-42.17%
Change (YTD)
-13.99%
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.39 B
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) is USD 2.39 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -5.21% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.53 B, a 6.42% change year over year.
-
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 2.37 B, a -12.55% change year over year.
-
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.71 B, a 7.30% change year over year.
-
Biogen Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.53 B, a 6.41% change year over year.
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.87
600276.SS
-0.17
-2.10%
Takeda Pharmaceutical Company Limited
USD 29.30
4502.T
-0.27
-0.91%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.87
600276.SS
-0.17
-2.10%
Takeda Pharmaceutical Company Limited
USD 29.30
4502.T
-0.27
-0.91%